Position in GILD
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$31,023,901
-$28,234,971 QoQ
Shares Held
222,601
-53.9% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026Andra AP-fonden holds $451,805,560 across 10 Drug Manufacturers - General names. GILD ranks #6 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
127,233 | $117,025,096 | |
| 2 | JNJ |
Johnson & Johnson
|
397,877 | $97,257,053 | |
| 3 | ABBV |
AbbVie Inc.
|
283,811 | $61,726,054 | |
| 4 | AZN |
Astrazeneca PLC
|
236,302 | $46,603,480 | |
| 5 | MRK |
Merck & Co., Inc.
|
364,485 | $43,843,900 | |
| 6 | GILD |
Gilead Sciences, Inc.
This page
|
222,601 | $31,023,901 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
332,662 | $20,175,950 | |
| 8 | AMGN |
Amgen Inc
|
50,366 | $17,721,277 |
All Filings in GILD
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $31,023,901 | 222,601 | Shares | Sole | 2026-05-08 | |
| 2025-12-31 | $59,258,872 | 482,800 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $66,322,500 | 597,500 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $64,060,686 | 577,800 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $26,970,435 | 240,700 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $29,724,666 | 321,800 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $33,410,240 | 398,500 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $28,589,787 | 416,700 | Shares | Sole | 2024-08-07 | |
| 2024-03-31 | $41,964,925 | 572,900 | Shares | Sole | 2024-05-13 | |
| 2023-06-30 | $17,988,138 | 233,400 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $22,294,039 | 268,700 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $15,032,335 | 175,100 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $10,234,371 | 165,900 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,932,867 | 160,700 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $11,225,506 | 154,600 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $12,475,210 | 178,600 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $11,609,796 | 168,600 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $6,643,964 | 102,800 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $7,783,536 | 133,600 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $7,235,255 | 114,500 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $9,255,882 | 120,300 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $9,561,804 | 127,900 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||